These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
328 related items for PubMed ID: 24585389
1. Lyophilized silica lipid hybrid (SLH) carriers for poorly water-soluble drugs: physicochemical and in vitro pharmaceutical investigations. Yasmin R, Tan A, Bremmell KE, Prestidge CA. J Pharm Sci; 2014 Sep; 103(9):2950-2959. PubMed ID: 24585389 [Abstract] [Full Text] [Related]
2. Pluronic-Functionalized Silica-Lipid Hybrid Microparticles: Improving the Oral Delivery of Poorly Water-Soluble Weak Bases. Rao S, Richter K, Nguyen TH, Boyd BJ, Porter CJ, Tan A, Prestidge CA. Mol Pharm; 2015 Dec 07; 12(12):4424-33. PubMed ID: 26523928 [Abstract] [Full Text] [Related]
3. Silica encapsulated lipid-based drug delivery systems for reducing the fed/fasted variations of ziprasidone in vitro. Dening TJ, Rao S, Thomas N, Prestidge CA. Eur J Pharm Biopharm; 2016 Apr 07; 101():33-42. PubMed ID: 26812284 [Abstract] [Full Text] [Related]
4. Nanocrystal-silica-lipid hybrid particles for the improved oral delivery of ziprasidone in vitro. Meola TR, Dening TJ, Prestidge CA. Eur J Pharm Biopharm; 2018 Aug 07; 129():145-153. PubMed ID: 29857135 [Abstract] [Full Text] [Related]
5. Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs. Tan A, Simovic S, Davey AK, Rades T, Prestidge CA. J Control Release; 2009 Feb 20; 134(1):62-70. PubMed ID: 19013488 [Abstract] [Full Text] [Related]
6. Silica nanoparticles to control the lipase-mediated digestion of lipid-based oral delivery systems. Tan A, Simovic S, Davey AK, Rades T, Boyd BJ, Prestidge CA. Mol Pharm; 2010 Apr 05; 7(2):522-32. PubMed ID: 20063867 [Abstract] [Full Text] [Related]
8. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs. Simovic S, Heard P, Hui H, Song Y, Peddie F, Davey AK, Lewis A, Rades T, Prestidge CA. Mol Pharm; 2009 Apr 05; 6(3):861-72. PubMed ID: 19358600 [Abstract] [Full Text] [Related]
10. Silica-lipid hybrid (SLH) versus non-lipid formulations for optimising the dose-dependent oral absorption of celecoxib. Tan A, Davey AK, Prestidge CA. Pharm Res; 2011 Sep 05; 28(9):2273-87. PubMed ID: 21560021 [Abstract] [Full Text] [Related]
13. Synergistic role of solid lipid and porous silica in improving the oral delivery of weakly basic poorly water soluble drugs. Yasmin R, Rao S, Bremmell K, Prestidge C. Eur J Pharm Sci; 2017 Jan 01; 96():508-514. PubMed ID: 27793717 [Abstract] [Full Text] [Related]
14. Enhancing the oral bioavailability of simvastatin with silica-lipid hybrid particles: The effect of supersaturation and silica geometry. Meola TR, Schultz HB, Peressin KF, Prestidge CA. Eur J Pharm Sci; 2020 Jul 01; 150():105357. PubMed ID: 32446169 [Abstract] [Full Text] [Related]
15. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate. Zhu W, Wan L, Zhang C, Gao Y, Zheng X, Jiang T, Wang S. Mater Sci Eng C Mater Biol Appl; 2014 Jan 01; 34():78-85. PubMed ID: 24268236 [Abstract] [Full Text] [Related]
16. An oral delivery system for indomethicin engineered from cationic lipid emulsions and silica nanoparticles. Simovic S, Hui H, Song Y, Davey AK, Rades T, Prestidge CA. J Control Release; 2010 May 10; 143(3):367-73. PubMed ID: 20079390 [Abstract] [Full Text] [Related]